Keyword: competitiveness

Strategy & Management

CEFIC’s Mid-Century Vision

06.12.2019 - The new political framework, set out by the Strategic Agenda and the Political Guidelines, has set bold priority areas for the next five years. In preparation for the new policy...

Markets & Companies

WEF’s Global Competitiveness Index 2018

28.11.2018 - Although global economic growth has been robust over the past two years, it remains fragile in the current changing economic and political context, according to the Global...

Markets & Companies

Trade and Industry Investment of the US Chemical Sector

25.11.2017 - The American chemical industry is a dynamic, forward-looking industry and a keystone of the domestic economy. One of the oldest industries in the United States, the US chemical...

Markets & Companies

The Middle East – More Opportunities than Risks

25.11.2017 - The Middle East chemical industry makes good money selling basic chemicals and uses local oil and gas in manufacturing. Hopes are high that the many major investments made by the...

Markets & Companies

Regaining Competitiveness in the Global Market

24.11.2017 - The European chemical industry is of major importance for economic development and wealth, providing modern products and materials and enabling solutions in virtually all sectors...

Strategy & Management

Cutting the Gordian Knot of Pharma Operating Model Complexity

27.09.2017 - Pharmaceutical companies have traditionally had complex operating models, but in recent years, complexity has reached a whole new level. Instead of continuously assessing their set...

Strategy & Management

A Future-oriented Industrial Policy Strategy

07.07.2017 - René van Sloten, CEFIC executive director industrial policy, explains why a holistic EU industrial policy strategy needs to be put in place – as called for by the Competitiveness...

Plant Construction & Process Technology

The Chemical Footprint in Pharma

26.04.2017 - The chemical industry is the most important supplier of the pharmaceutical industry, but it can´t keep pace with the economic strength and R&D intensity of pharma. This underlines...